SCHEMBL4097832

SCHEMBL4097832

CCCCCCCC/C=C\CCCCCCCCCCCC(=O)Oc1ccc(C=Cc2cc(O)cc(OC(=O)CCCCCCCCCCC/C=C\CCCCCCCC)c2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALB P02768 1/20 0.46
KMT2A Q03164 3/20 0.46
ELANE P08246 5/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
KDM4E B2RXH2 1/20 0.45
MEN1 O00255 1/20 0.45
LMNA P02545 1/20 0.45
TTR P02766 1/20 0.45
TP53 P04637 1/20 0.45
CYP3A4 P08684 1/20 0.45
MAPT P10636 1/20 0.45
POLM Q9NP87 1/20 0.44
POLK Q9UBT6 1/20 0.44
POLL Q9UGP5 1/20 0.44
POLH Q9Y253 1/20 0.44
CNR1 P21554 2/20 0.44
RET P07949 1/20 0.44
PSMB11 A5LHX3 1/20 0.44
PSMA7 O14818 1/20 0.44
PSMB1 P20618 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2516512 1.00 ALB (0.46) ALBKMT2AELANESMN1; SMN2KDM4E
SCHEMBL2515292 0.98 ALB (0.45) ALBKMT2AELANESMN1; SMN2KDM4E
SCHEMBL4092190 0.95 PSMB11 (0.49) ALBKMT2AELANEMEN1TTR
SCHEMBL2519715 0.95 PSMB11 (0.49) ALBKMT2AELANEMEN1TTR
SCHEMBL2520030 0.95 ALB (0.51) ALBKMT2AELANESMN1; SMN2KDM4E
SCHEMBL4098119 0.95 ALB (0.51) ALBKMT2AELANESMN1; SMN2KDM4E
SCHEMBL19873141 0.95 ALB (0.51) ALBKMT2AELANESMN1; SMN2KDM4E
SCHEMBL4097199 0.94 MGLL (0.45) KMT2ASMN1; SMN2KDM4EMEN1LMNA
SCHEMBL4099328 0.94 KMT2A (0.51) KMT2AELANESMN1; SMN2KDM4EMEN1
SCHEMBL2519160 0.94 KMT2A (0.51) KMT2AELANESMN1; SMN2KDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9295621-B2 Emulsion cosmetic compositions containing resveratrol derivatives and silicone surfactant ELC MANAGEMENT LLC (US) 2016-03-29 US disclosed
US-20090035240-A1 Aqueous Based Cosmetic Compositions Containing Resveratrol Derivatives And An Aqueous Phase Structuring Agent ELC MANAGEMENT LLC 2009-02-05 US disclosed
US-20090035237-A1 Emulsion Cosmetic Compositions Containing Resveratrol Derivatives And Silicone Surfactant ELC MANAGEMENT LLC 2009-02-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090035237-A1 Emulsion Cosmetic Compositions Containing Resveratrol Derivatives And Silicone Surfactant SMURF1, CUTA, SMURF2 ALB 1597/4885KMT2A 1425/4885ELANE 2550/4885
US-20090035240-A1 Aqueous Based Cosmetic Compositions Containing Resveratrol Derivatives And An Aqueous Phase Structuring Agent SMARCC1, RARG, RARA ALB 2833/4885KMT2A 1387/4885ELANE 3490/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.